Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s417928 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Mustafa K Shehata und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Alzheimer Disease, Nanostructures. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
- Department of Biochemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt.
ORCID-Profile: Mustafa K Shehata, Maher A Kamel
Zitieren
APA
Shehata, M. K., Ismail, A. A., & Kamel, M. A. (2023). Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s417928
Vancouver
Shehata MK, Ismail AA, Kamel MA. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s417928
BibTeX
@article{Shehata2023,
author = {Shehata, Mustafa K and Ismail, Assem A and Kamel, Maher A},
title = {Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s417928}
}
EUVIMED